Use of riluzole

MNMED_RILUZOLE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N07XX02

112

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

72

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

72

diagram downward connector

Include endpoints None

72

diagram downward connector
MNMED_RILUZOLE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 72 27 45
Unadjusted prevalence (%) 0.02 0.01 0.03
Mean age at first event (years) 65.24 67.08 64.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MNMED_RILUZOLE – Use of riluzole
GWS hits:

Survival analyses between endpoints

Plot

before Use of riluzole
after Use of riluzole

loading spinner Loading survival analyses plot